I appreciate that, Chair. I would suggest, though, that it's important that Canadians understand what transparency is and what it is not. We know very clearly, from the mention in this article, that this government really struggles with the concept of transparency. That is also why it is incredibly important that we are very, very clear with respect to what this bill is and what it isn't.
Again, just to underline this, or underscore it, talking about transparency, we have the industry minister suggesting that creating a vaccine facility is like putting somebody on the moon. That's just incomprehensible to everyday Canadians. We can come back to some of these points. There's no issue with me with continuing to belabour it.
However, this bill is clearly related to prescription drugs and related products intended for contraception or the treatment of diabetes, and for support, etc. That is why it's incredibly important that we add that here, so that there's clarity, there's transparency and there's responsibility on behalf of Canadians. This is not a universal pharmacare bill in any way, shape or form. This is a pharmacare pamphlet of four pages.
The final thing I will say, Chair, is that it would be shocking to me that the costly coalition around this table, not including the Conservative members—I know the Bloc member certainly does not want to support this bill, considering the fact that Quebec has a pharmacare program already—would allow Canadians to think that this particular pamphlet is a universal pharmacare bill, which as of yet has not defined even the medications related to contraception and to diabetes.
On behalf of Canadians, I would implore those around the table to vote for CPC-7, as it is important for transparency and clarity on behalf of Canadians.
Thank you, Chair.